Filing Details

Accession Number:
0001209191-21-042786
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-23 17:18:29
Reporting Period:
2021-06-22
Accepted Time:
2021-06-23 17:18:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662244 Cyteir Therapeutics Inc. CYT () G7
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1388325 A/S Holdings Novo Tuborg Havnevej 19
Hellerup G7 2900
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-22 4,562,636 $0.00 4,562,636 No 4 C Direct
Common Stock Acquisiton 2021-06-22 277,777 $18.00 4,840,413 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock SERIES B CONVERTIBLE PREFERRED STOCK Disposition 2021-06-22 14,000,000 $0.00 4,107,017 $0.00
Common Stock SERIES C CONVERTIBLE PREFERRED STOCK Disposition 2021-06-22 1,553,116 $0.00 455,619 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into shares of common stock, based on a conversion ratio of 1 share of preferred stock for 0.2934 shares of common stock, upon the completion of the Issuer's initial public offering. These shares have no expiration date.
  2. Represents a purchase from the underwriters in the Issuer's initial public offering.